Kobayashi Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kobayashi Pharmaceutical Co Ltd with three other
companies in this sector in Japan:
Sawai Pharmaceutical Co., Ltd.
sales of 168.07 billion Japanese Yen [US$1.50 billion]
of which 80%
was Japan-Operating segment),
Tsumura & Co
(117.88 billion Japanese Yen [US$1.05 billion]
of which 100%
was Pharmaceutical Items), and
Nichi-Iko Pharmaceutical Company Limited
(164.72 billion Japanese Yen [US$1.47 billion]
of which 23%
Kobayashi Pharmaceutical Co Ltd reported sales of ¥167.48 billion (US$1.49 billion)
December of 2018.
increase of 6.8%
versus 2017, when the company's sales were ¥156.76 billion.
Sales of Overseas Manufacturing and Sale of Househo saw an increase
that was more than double the company's growth rate: sales were up
17.8% in 2018, from
¥21.77 billion to ¥25.65 billion.
Not all segments of Kobayashi Pharmaceutical Co Ltd experienced an increase in sales in 2018:
sales of Other Businesses fell 8.5% to ¥1.21 billion.
(However, this segment's sales were only a very small portion of the company's overall sales).